Showing results (71-80 of 505) with videos related to
Sort By:
Pageof 51
Expert Review of Cardiovascular Therapy|July 4, 2007
Role of Factor XII in hemostasis and thrombosis: clinical implicationsThomas Renné, David GailaniCurrent Opinion in Hematology|August 3, 2020
The rebirth of the contact pathway: a new therapeutic targetPriyanka Srivastava, David GailaniBlood|December 24, 2023
Targeting factor XI and factor XIa to prevent thrombosisDavid Gailani, Andras GruberSeminars in Thrombosis and Hemostasis|September 13, 2017
Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial SurfacesBenjamin Tillman, David GailaniJournal of Thrombosis and Haemostasis : JTH|November 4, 2021
A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitorsOphira Salomon, David GailaniArteriosclerosis, Thrombosis, and Vascular Biology|October 6, 2007
Intrinsic pathway of coagulation and arterial thrombosisDavid Gailani, Thomas RennéResearch and Practice in Thrombosis and Haemostasis|June 17, 2020
The contact activation system as a potential therapeutic target in patients with COVID-19Joseph J Shatzel, Emma P DeLoughery, Christina U Lorentz, et al.Journal of Thrombosis and Haemostasis : JTH|July 13, 2025
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generationRuiqi Yin, James C Fredenburgh, Jeffrey I WeitzThrombosis and Haemostasis|December 8, 2009
Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysisXufang Bai, Jeffrey I Weitz, Peter L GrossChest|July 24, 2008
New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jeffrey I Weitz, Jack Hirsh, Meyer M SamamaPageof 51